Is Tenet Healthcare (THC) A Suitable Pick for Value Investors?

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Tenet Healthcare Corporation THC stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, Tenet Healthcare has a trailing twelve months PE ratio of 16.62, as you can see in the chart below:

This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 compares in at about 20.78. If we focus on the stock’s long-term PE trend, the current level puts Tenet Healthcare’s current PE ratio slightly above its midpoint (which is 14.96) over the past five years.

Further, the stock’s PE compares favorably with the Zacks Medical sector’s trailing twelve months PE ratio, which stands at 23.51. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.

We should also point out that Tenet Healthcare has a forward PE ratio (price relative to this year’s earnings) of just 12.87, so it is fair to say that a slightly more value-oriented path may be ahead for Tenet Healthcare’s stock in the near term too.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, Tenet Healthcare has a P/S ratio of about 0.21. This is substantially lower than the S&P 500 average, which comes in at 3.59 right now. Also, as we can see in the chart below, this is somewhat below the highs for this stock in particular over the past few years.

If anything, this suggests some level of undervalued trading—at least compared to historical norms.  
 
Broad Value Outlook

In aggregate, Tenet Healthcare currently has a Value Style Score of A, putting it into the top 20% of all stocks we cover from this look. This makes THC a solid choice for value investors, and some of its other key metrics make this pretty clear too.

For example, the PEG ratio for Premier is just 0.68, a level that is slightly lower than the industry average of 1.13. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Additionally, its P/CF ratio (another great indicator of value) comes in at 3.56, which is somewhat better than the industry average of 5.55. Clearly, THC is a solid choice on the value front from multiple angles.

What About the Stock Overall?

Though Tenet Healthcare might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth grade of A and a Momentum score of C. This gives THC a VGM score—or its overarching fundamental grade—of A. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been encouraging. The current quarter has seen one estimate go higher in the past sixty days compared to none lower, while the current year estimate has seen one upward and one downward revision in the same time period.

This has had a noticeable impact on the consensus estimate, as the current quarter consensus estimate has risen 2% in the past two months, while the current year estimate has nudged up 1.1%. You can see the consensus estimate trend and recent price action for the stock in the chart below:

Tenet Healthcare Corporation Price and Consensus

 

Tenet Healthcare Corporation Price and Consensus

Tenet Healthcare Corporation price-consensus-chart | Tenet Healthcare Corporation Quote

Even though Tenet Healthcare has a better estimates trend, the stock has just a Zacks Rank #3 (Hold). That is why we are looking for in-line performance from the company in the near term.

Bottom Line

Tenet Healthcare is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Moreover, a strong industry rank (top 20% out of more than 250 industries) further supports the growth potential of the stock. However, with a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past one year, the sector has clearly underperformed the broader market, as you can see below:

So, value investors might want to wait for industry trend to turn favorable in this name first, but once that happens, this stock could be a compelling pick.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.